No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDLX240719C14000
- 3.50
- 0.000.00%
15min DelayClose May 7 14:24 ET
0.00High0.00Low
0.00Open3.50Pre Close0 Volume30 Open Interest14.00Strike Price0.00Turnover0.00%IV91.26%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry3.50Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.61Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Cardlytics Inc : BofA Global Research Reinstates Coverage With Neutral Rating; Price Objective $11
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
Express News | B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
BofA Securities Initiates Cardlytics(CDLX.US) With Hold Rating, Announces Target Price $11
Express News | Cardlytics Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $14
Cardlytics Initiated at Outperform by Northland Capital Markets
Comments
$Cardlytics(CDLX.US$ DEMON NET 🤔
$Cardlytics(CDLX.US$ 15 tonight!!
Cardlytics' unique position with access to large datasets could be a boon as AI adoption progresses. Its acquisition of Dosh is expected to strengthen its position in the underbanked category. CDLX stock is deemed a 'Strong Buy'.
4
1
$Cardlytics(CDLX.US$ Clifford Sosin, 10% Owner, around March 15, 2024, executed a purchase for 661,715 shares in Cardlytics (CDLX) for $8,963,859. Following the Form 4 filing with the SEC, Sosin has control over a total of 6,023,676 shares of the company, with 6,023,676 shares controlled indirectly.
Read more